Stephen J Tulipano - Net Worth and Insider Trading
Stephen J Tulipano Net Worth
The estimated net worth of Stephen J Tulipano is at least $243,828 dollars as of 2024-04-25. Stephen J Tulipano is the CFO of Stoke Therapeutics Inc and owns about 20,746 shares of Stoke Therapeutics Inc (STOK) stock worth over $230,696. Stephen J Tulipano is also the CFO of Aldeyra Therapeutics Inc and owns about 3,333 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $13,132. Details can be seen in Stephen J Tulipano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen J Tulipano has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).
Transaction Summary of Stephen J Tulipano
Stephen J Tulipano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen J Tulipano owns 2 companies in total, including Stoke Therapeutics Inc (STOK) , and Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Stephen J Tulipano’s form 4 insider trades.
Insider Ownership Summary of Stephen J Tulipano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-19 | CFO |
| ALDX | Aldeyra Therapeutics Inc | 2017-02-17 | Chief Financial Officer |
Stephen J Tulipano Latest Holdings Summary
Stephen J Tulipano currently owns a total of 2 stocks. Among these stocks, Stephen J Tulipano owns 20,746 shares of Stoke Therapeutics Inc (STOK) as of March 19, 2024, with a value of $230,696 and a weighting of 94.61%. Stephen J Tulipano also owns 3,333 shares of Aldeyra Therapeutics Inc (ALDX) as of February 17, 2017, with a value of $13,132 and a weighting of 5.39%.
Latest Holdings of Stephen J Tulipano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-19 | 20,746 | 11.12 | 230,696 |
| ALDX | Aldeyra Therapeutics Inc | 2017-02-17 | 3,333 | 3.94 | 13,132 |
Holding Weightings of Stephen J Tulipano
Stephen J Tulipano Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen J Tulipano has made a total of 3 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 4,116 shares on March 19, 2024, which brought Stephen J Tulipano around $25,108.
According to the SEC Form 4 filings, Stephen J Tulipano has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 3,333 shares on February 17, 2017, which cost Stephen J Tulipano around $14,999.
Insider Trading History of Stephen J Tulipano
- 1
Stephen J Tulipano Trading Performance
GuruFocus tracks the stock performance after each of Stephen J Tulipano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen J Tulipano is -12.75%. GuruFocus also compares Stephen J Tulipano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen J Tulipano within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen J Tulipano's insider trading performs compared to the benchmark.
Performance of Stephen J Tulipano
Average Return
42.16%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.92 | -12.75 | -15.69 | 42.16 | 23.42 | 0.13 |
| Relative Return to S&P 500(%) | 2.77 | -13 | -19.04 | 25.95 | 14.74 | -12.77 |
Stephen J Tulipano Ownership Network
Ownership Network List of Stephen J Tulipano
Ownership Network Relation of Stephen J Tulipano
Stephen J Tulipano Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Stephen J Tulipano is the CFO of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include 10 percent owner Skorpios Trust , General Counsel & Corp Sec Jonathan Allan , and director & CEO Kaye Edward M. Md .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Stephen J Tulipano made 1 insider transaction in Stoke Therapeutics Inc (STOK) with a net sale of 4,116. Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 139,116 shares made by Barry Ticho , a net sale of 9,423 shares made by Jonathan Allan , and a net sale of 3,600,000 shares made by Skorpios Trust .
In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,767,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,767,921 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Stephen J Tulipano Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen J Tulipano. You might contact Stephen J Tulipano via mailing address: C/o Javelin Pharmaceuticals, Inc., 125 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
